Why Dupixent Keeps Regeneron A Top Big Pharma Pick
Source: SeekingAlpha
2026-02-27 08:00:00 ET
Shares of Regeneron Pharmaceuticals ( REGN ), my favorite on the monoclonal antibodies market, have risen 11.5% since the article "Regeneron Pharmaceuticals: Is Wall Street Finally Paying Attention?" ....
Read the full article on Seeking Alpha
For further details see:
Why Dupixent Keeps Regeneron A Top Big Pharma Pick
Biogen Inc.
NASDAQ: BIIB
BIIB Trading
0.47% G/L:
$183.02 Last:
65,319 Volume:
$183.91 Open:
BIIB Latest News
March 05, 2026 07:30:00 am
Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences
BIIB Stock Data
$28,113,797,416
145,290,943
N/A
471
N/A
Pharmaceuticals
Healthcare
US
Cambridge
